Search: WFRF:(Prince Jonathan A.)
> (2005-2009) >
Genetic association...
-
Johansson, Annica,1969Gothenburg University,Göteborgs universitet,Institutionen för klinisk neurovetenskap, Sektionen för psykiatri,Institute of Clinical Neurosciences, Section of Psychiatry
(author)
Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease
- Article/chapterEnglish2005
Publisher, publication year, extent ...
-
2005-11-17
-
S. Karger AG,2005
Numbers
-
LIBRIS-ID:oai:gup.ub.gu.se/80163
-
https://gup.ub.gu.se/publication/80163URI
-
https://doi.org/10.1159/000088634DOI
-
https://lup.lub.lu.se/record/898726URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:1931802URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
We have recently reported that a polymorphism in the cell division cycle <i>(CDC2) </i>gene, designated Ex6 + 7I/D, is associated with Alzheimer’s disease (AD). The <i>CDC2</i> gene is located on chromosome 10q21.1 close to the marker D10S1225 linked to AD. Active cdc2 accumulates in neurons containing neurofibrillary tangles (NFT), a process that can precede the formation of NFT. Therefore, <i>CDC2 </i>is a promising candidate susceptibility gene for AD. We investigated the possible effects of the <i>CDC2</i> polymorphism on cerebrospinal fluid (CSF) biomarkers in AD patients. <i>CDC2</i> genotypes were evaluated in relation to CSF protein levels of total tau, phospho-tau and β-amyloid<sub>(1–42)</sub> in AD patients and control individuals, and in relation to the amount of senile plaques and NFT in the frontal cortex and in the hippocampus in patients with autopsy-proven AD and controls. The <i>CDC2</i> Ex6 + 7I allele was associated with a gene dose-dependent increase of CSF total tau levels (F<sub>2, 626</sub> = 7.0, p = 0.001) and the homozygous <i>CDC2</i> Ex6 + 7II genotype was significantly more frequent among AD patients compared to controls (p = 0.006, OR = 1.57, 95% CI 1.13–2.17). Our results provide further evidence for an involvement of cdc2 in the pathogenesis of AD.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Zetterberg, Henrik,1973Gothenburg University,Göteborgs universitet,Institutionen för klinisk neurovetenskap, Sektionen för laborativ neurovetenskap,Institute of Clinical Neurosciences, Section of Experimental Neuroscience(Swepub:gu)xzethe
(author)
-
Hampel, Harald
(author)
-
Buerger, Katharina
(author)
-
Prince, Jonathan A.
(author)
-
Minthon, LennartLund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups(Swepub:lu)psyk-lmi
(author)
-
Wahlund, Lars-OlofKarolinska Institutet
(author)
-
Blennow, Kaj,1958Gothenburg University,Göteborgs universitet,Institutionen för klinisk neurovetenskap, Sektionen för laborativ neurovetenskap,Institute of Clinical Neurosciences, Section of Experimental Neuroscience(Swepub:gu)xbleka
(author)
-
Göteborgs universitetInstitutionen för klinisk neurovetenskap, Sektionen för psykiatri
(creator_code:org_t)
Related titles
-
In:Dementia and Geriatric Cognitive Disorders: S. Karger AG20:6, s. 367-3741420-80081421-9824
Internet link
Find in a library
To the university's database